KALA BIO, Inc. (KALA) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -2,872.05%.
Criteria proven by this page:
Overall SharesGrow Score: 38/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2015 | -19.2 | -0.93 | -55.16 | 7,101.54 | - |
| 2016 | -9.6 | -0.10 | -3.64 | 0.00 | - |
| 2017 | -9.3 | -2.75 | 4.39 | 0.00 | - |
| 2018 | -2.0 | -0.08 | 1.25 | 0.00 | - |
| 2019 | -1.3 | -0.07 | 4.25 | 20.78 | - |
| 2020 | -3.4 | 0.10 | 3.55 | 55.82 | - |
| 2021 | -0.6 | -0.06 | 4.70 | 7.02 | - |
| 2022 | -1.3 | 0.02 | 3.06 | 14.91 | - |
| 2023 | -0.4 | 0.01 | 2.27 | 0.00 | - |
| 2024 | -1.0 | 0.02 | 3.11 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2015 | $-48.26 | $45K | $-16.68M | -37071.1% |
| 2016 | $-95.95 | $0.00 | $-33.17M | - |
| 2017 | $-305.74 | $0.00 | $-42.21M | - |
| 2018 | $-124.73 | $0.00 | $-66.74M | - |
| 2019 | $-149.06 | $6.07M | $-101.98M | -1679% |
| 2020 | $-106.92 | $6.36M | $-112M | -1760.5% |
| 2021 | $-116.79 | $11.24M | $-152.3M | -1354.9% |
| 2022 | $-0.15 | $3.89M | $-223K | -5.7% |
| 2023 | $-17.35 | $0.00 | $-42.2M | - |
| 2024 | $-1.01 | $0.00 | $-38.51M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.53 | $-0.53 – $-0.53 | $25M | $25M – $25M | 1 |
| 2027 | $-0.40 | $-0.40 – $-0.40 | $26.12M | $26.12M – $26.12M | 1 |
| 2028 | $-0.18 | $-0.18 – $-0.18 | $134.23M | $134.23M – $134.23M | 1 |
| 2029 | $-0.17 | $-0.17 – $-0.17 | $229.33M | $229.33M – $229.33M | 1 |
